Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study
- PMID: 31385063
- DOI: 10.1007/s00394-019-02070-w
Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study
Abstract
Purpose: To assess the association between the consumption of non-soy legumes and different subtypes of non-soy legumes and serum uric acid (SUA) or hyperuricemia in elderly individuals with overweight or obesity and metabolic syndrome.
Methods: A cross-sectional analysis was conducted in the framework of the PREDIMED-Plus study. We included 6329 participants with information on non-soy legume consumption and SUA levels. Non-soy legume consumption was estimated using a semi-quantitative food frequency questionnaire. Linear regression models and Cox regression models were used to assess the associations between tertiles of non-soy legume consumption, different subtypes of non-soy legume consumption and SUA levels or hyperuricemia prevalence, respectively.
Results: Individuals in the highest tertile (T3) of total non-soy legume, lentil and pea consumption, had 0.14 mg/dL, 0.19 mg/dL and 0.12 mg/dL lower SUA levels, respectively, compared to those in the lowest tertile (T1), which was considered the reference one. Chickpea and dry bean consumption showed no association. In multivariable models, participants located in the top tertile of total non-soy legumes [prevalence ratio (PR): 0.89; 95% CI 0.82-0.97; p trend = 0.01, lentils (PR: 0.89; 95% CI 0.82-0.97; p trend = 0.01), dry beans (PR: 0.91; 95% C: 0.84-0.99; p trend = 0.03) and peas (PR: 0.89; 95% CI 0.82-0.97; p trend = 0.01)] presented a lower prevalence of hyperuricemia (vs. the bottom tertile). Chickpea consumption was not associated with hyperuricemia prevalence.
Conclusions: In this study of elderly subjects with metabolic syndrome, we observed that despite being a purine-rich food, non-soy legumes were inversely associated with SUA levels and hyperuricemia prevalence.
Trial registration: ISRCTN89898870. Registration date: 24 July 2014.
Keywords: Hyperuricemia; Non-soy legumes; PREDIMED-Plus; Serum uric acid.
References
-
- Bhole V, de Vera M, Rahman MM et al (2010) Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 62:1069–1076. https://doi.org/10.1002/art.27338 - DOI - PubMed
-
- Babio N, Martínez-González MA, Estruch R et al (2015) Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study. Nutr Metab Cardiovasc Dis 25:173–180. https://doi.org/10.1016/j.numecd.2014.10.006 - DOI - PubMed
-
- Lv Q, Meng X-F, He F-F et al (2013) High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One 8:e56864. https://doi.org/10.1371/journal.pone.0056864 - DOI - PubMed - PMC
-
- Borghi C, Verardi FM, Pareo I et al (2014) Hyperuricemia and cardiovascular disease risk. Expert Rev Cardiovasc Ther 12:1219–1225. https://doi.org/10.1586/14779072.2014.957675 - DOI - PubMed
-
- Maiuolo J, Oppedisano F, Gratteri S et al (2016) Regulation of uric acid metabolism and excretion. Int J Cardiol 213:8–14. https://doi.org/10.1016/j.ijcard.2015.08.109 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- PI13/00492/Instituto de Salud Carlos III
- PI16/00662/Instituto de Salud Carlos III
- PI17/01732/Instituto de Salud Carlos III
- PI16/01120/Instituto de Salud Carlos III
- PI14/00696/Instituto de Salud Carlos III
- PI17/00855/Instituto de Salud Carlos III
- PI14/01471/Instituto de Salud Carlos III
- PI17/01347/Instituto de Salud Carlos III
- PI13/00673/Instituto de Salud Carlos III
- PI16/00473)/Instituto de Salud Carlos III
- PI14/01919/Instituto de Salud Carlos III
- PI17/00926/Instituto de Salud Carlos III
- PI14/00853/Instituto de Salud Carlos III
- PI17/00525/Instituto de Salud Carlos III
- PI13/02184/Instituto de Salud Carlos III
- PI16/00381/Instituto de Salud Carlos III
- PI13/00233/Instituto de Salud Carlos III
- PI16/00533/Instituto de Salud Carlos III
- PI13/00462/Instituto de Salud Carlos III
- PI16/00501/Instituto de Salud Carlos III
- PI14/01722/Instituto de Salud Carlos III
- PI17/00764/Instituto de Salud Carlos III
- PI13/01090/Instituto de Salud Carlos III
- PI16/01522/Instituto de Salud Carlos III
- PI13/01056/Instituto de Salud Carlos III
- PI13/00728/Instituto de Salud Carlos III
- PI16/00366/Instituto de Salud Carlos III
- PI13/00272/Instituto de Salud Carlos III
- PI16/01873/Instituto de Salud Carlos III
- PI13/01123/Instituto de Salud Carlos III
- PI16/01094/Instituto de Salud Carlos III
- PI14/00618/Instituto de Salud Carlos III
- PI17/01183/Instituto de Salud Carlos III
- PI14/01374/Instituto de Salud Carlos III
- PI14/00972/Instituto de Salud Carlos III
- PI17/00508/Instituto de Salud Carlos III
- PI14/00636/Instituto de Salud Carlos III
- PI17/01827/Instituto de Salud Carlos III
- PI14/00728/Instituto de Salud Carlos III
- PI17/00215/Instituto de Salud Carlos III
- PI14/01206/Instituto de Salud Carlos III
- PI17/01441/Instituto de Salud Carlos III
- PI17/00532/Instituto de Salud Carlos III
- JR17/00022/Instituto de Salud Carlos III
- 340918/H2020 European Research Council
- 2013ACUP00194/Recercaixa
- PI0458/2013/Consejería de Salud de la Junta de Andalucía
- PS0358/2016/Consejería de Salud de la Junta de Andalucía
- PI0137/2018/Consejería de Salud de la Junta de Andalucía
- PROMETEO/2017/017/Conselleria d'Educació, Investigació, Cultura i Esport (ES)
- CB06/03/European Regional Development Fund
LinkOut - more resources
Full Text Sources
Medical
Research Materials